Reprint

Advances in the Development of New Drugs and Treatment Targets for Brain Cancers

Edited by
June 2024
176 pages
  • ISBN978-3-7258-1403-9 (Hardback)
  • ISBN978-3-7258-1404-6 (PDF)

This book is a reprint of the Special Issue Advances in the Development of New Drugs and Treatment Targets for Brain Cancers that was published in

Biology & Life Sciences
Computer Science & Mathematics
Medicine & Pharmacology
Public Health & Healthcare
Summary

The Special Issue features original research articles and review articles that discuss new therapy tactics and target medications, emphasizing the significance of brain tumors at the cellular and molecular levels. In recent decades, potent chemotherapeutic agents, oligonucleotides, and antibodies for targeted therapy, multifunctional nanomedicines, immunotherapies, and cell-based therapies have been developed and proposed to overcome most of the issues that arise due to the locations of brain tumors and their biological barriers. Ongoing research is focused on comprehending the biology of brain tumors, discovering new treatment targets, and creating breakthrough medicines like immunotherapy and tailored drug delivery systems. These endeavors show potential for enhancing results and increasing survival rates in the future.

Format
  • Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
locomotion; glioblastoma; anastrozole; glioblastoma; macrophages; monocytes; tumor microenvironment; targeted therapy; cell-based therapy; glioblastoma; melatonin; albendazole; albendazole sulfoxide; synergism; astrocytoma; glioblastoma; glucose; ketones; metabolism; diet; high-grade glioma; actin alpha 2; smooth muscle (ACTA2); actin alpha; cardiac muscle 1 (ACTC1); cytoskeleton; cell migration; recurrence; low-grade gliomas; astrocytoma; oligodendroglioma; ependymoma; rare low-grade gliomas; pediatric low-grade gliomas; neuropathology and classification; molecular pathways; outcome; treatment strategies; surgery; radiation therapy; targeted therapies; immune therapies; synthesis; chalcones; glioblastoma; nanotechnology; polymersomes; glioblastoma; miRNA-125b; STAT3; inflammatory cytokines; rutin; brain tumors; childhood cancers; pediatrics; nanoparticles; liposomes; glioblastoma; magnetic resonance imaging; magnetic resonance spectroscopy; HRMAS; preclinical models; n/a

Related Books

May 2021

The Immunology and Biology of Brain Tumors

Medicine & Pharmacology
October 2019

Anticancer Drugs

Medicine & Pharmacology
January 2019

Update in Pediatric Neuro-Oncology

Medicine & Pharmacology